BENZONATATE
- Product NDC
- 42708-082
- 11-digit product format
- 427080082
- Labeler code
- 42708
- Product ID
- 42708-082_4682a652-1196-5854-e063-6394a90a4c30
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BENZONATATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- QPharma, Inc.
- Application
- ANDA040627
- Marketing category
- ANDA
- Marketing start
- 2017-03-22
- Substance
- BENZONATATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- BENZONATATE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BENZONATATE | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5P4DHS6ENR |
| Rxcui | 283417 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42708-082-21 | BENZONATATE | 21 in 1 BOTTLE | CAPSULE | 21 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42708-082 | BENZONATATE CAPSULE [QPHARMA, INC.] | 5 | Current NDC, Legacy NDC, 1 package rows | 20250521_55c4ae18-3e37-4caf-9fdb-9d307970b5f9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42708-082-21 | 42708008221 | 21 CAPSULE in 1 BOTTLE (42708-082-21) | 21 capsule | 2019-02-28 | 0000-00-00 | Yes | No | Current |